These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32079396)

  • 1. Protein-Mutation-Induced Conformational Changes of the DNA and Nuclease Domain in CRISPR/Cas9 Systems by Molecular Dynamics Simulations.
    Ray A; Di Felice R
    J Phys Chem B; 2020 Mar; 124(11):2168-2179. PubMed ID: 32079396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordinated Actions of Cas9 HNH and RuvC Nuclease Domains Are Regulated by the Bridge Helix and the Target DNA Sequence.
    Babu K; Kathiresan V; Kumari P; Newsom S; Parameshwaran HP; Chen X; Liu J; Qin PZ; Rajan R
    Biochemistry; 2021 Dec; 60(49):3783-3800. PubMed ID: 34757726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Basis for Reduced Dynamics of Three Engineered HNH Endonuclease Lys-to-Ala Mutants for the Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-Associated 9 (CRISPR/Cas9) Enzyme.
    Wang J; Skeens E; Arantes PR; Maschietto F; Allen B; Kyro GW; Lisi GP; Palermo G; Batista VS
    Biochemistry; 2022 May; 61(9):785-794. PubMed ID: 35420793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CRISPR AcrIIC3 discriminates between Cas9 orthologs via targeting the variable surface of the HNH nuclease domain.
    Kim Y; Lee SJ; Yoon HJ; Kim NK; Lee BJ; Suh JY
    FEBS J; 2019 Dec; 286(23):4661-4674. PubMed ID: 31389128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protospacer Adjacent Motif-Induced Allostery Activates CRISPR-Cas9.
    Palermo G; Ricci CG; Fernando A; Basak R; Jinek M; Rivalta I; Batista VS; McCammon JA
    J Am Chem Soc; 2017 Nov; 139(45):16028-16031. PubMed ID: 28764328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Insights Revealed by the Kinetic Mechanism of CRISPR/Cas9.
    Raper AT; Stephenson AA; Suo Z
    J Am Chem Soc; 2018 Feb; 140(8):2971-2984. PubMed ID: 29442507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leveraging QM/MM and Molecular Dynamics Simulations to Decipher the Reaction Mechanism of the Cas9 HNH Domain to Investigate Off-Target Effects.
    Maghsoud Y; Jayasinghe-Arachchige VM; Kumari P; Cisneros GA; Liu J
    J Chem Inf Model; 2023 Nov; 63(21):6834-6850. PubMed ID: 37877218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Divalent Metal Binding by SpyCas9's RuvC Active Site Contributes to Nonspecific DNA Cleavage.
    Newsom SN; Wang DS; Rostami S; Schuster I; Parameshwaran HP; Joseph YG; Qin PZ; Liu J; Rajan R
    CRISPR J; 2023 Dec; 6(6):527-542. PubMed ID: 38108519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-time observation of Cas9 postcatalytic domain motions.
    Wang Y; Mallon J; Wang H; Singh D; Hyun Jo M; Hua B; Bailey S; Ha T
    Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33443184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structures of a CRISPR-Cas9 R-loop complex primed for DNA cleavage.
    Jiang F; Taylor DW; Chen JS; Kornfeld JE; Zhou K; Thompson AJ; Nogales E; Doudna JA
    Science; 2016 Feb; 351(6275):867-71. PubMed ID: 26841432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key role of the REC lobe during CRISPR-Cas9 activation by 'sensing', 'regulating', and 'locking' the catalytic HNH domain.
    Palermo G; Chen JS; Ricci CG; Rivalta I; Jinek M; Batista VS; Doudna JA; McCammon JA
    Q Rev Biophys; 2018; 51():. PubMed ID: 30555184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9 for genome editing: progress, implications and challenges.
    Zhang F; Wen Y; Guo X
    Hum Mol Genet; 2014 Sep; 23(R1):R40-6. PubMed ID: 24651067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bidirectional Degradation of DNA Cleavage Products Catalyzed by CRISPR/Cas9.
    Stephenson AA; Raper AT; Suo Z
    J Am Chem Soc; 2018 Mar; 140(10):3743-3750. PubMed ID: 29461055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementing accelerated dynamics to unravel the effects of high-fidelity Cas9 mutants on target DNA and guide RNA hybrid stability.
    Vora DS; Jaiswal AK; Sundar D
    J Biomol Struct Dyn; 2023; 41(13):6178-6190. PubMed ID: 35882048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structures of Neisseria meningitidis Cas9 Complexes in Catalytically Poised and Anti-CRISPR-Inhibited States.
    Sun W; Yang J; Cheng Z; Amrani N; Liu C; Wang K; Ibraheim R; Edraki A; Huang X; Wang M; Wang J; Liu L; Sheng G; Yang Y; Lou J; Sontheimer EJ; Wang Y
    Mol Cell; 2019 Dec; 76(6):938-952.e5. PubMed ID: 31668930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cas9, Cpf1 and C2c1/2/3-What's next?
    Nakade S; Yamamoto T; Sakuma T
    Bioengineered; 2017 May; 8(3):265-273. PubMed ID: 28140746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editing of the Bacillus subtilis Genome by the CRISPR-Cas9 System.
    Altenbuchner J
    Appl Environ Microbiol; 2016 Sep; 82(17):5421-7. PubMed ID: 27342565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A beginner's guide to gene editing.
    Harrison PT; Hart S
    Exp Physiol; 2018 Apr; 103(4):439-448. PubMed ID: 29282799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural insights into DNA cleavage activation of CRISPR-Cas9 system.
    Huai C; Li G; Yao R; Zhang Y; Cao M; Kong L; Jia C; Yuan H; Chen H; Lu D; Huang Q
    Nat Commun; 2017 Nov; 8(1):1375. PubMed ID: 29123204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.